Emicizumab-kxwh Subcutaneous and Lotensin HCT
Determining the interaction of Emicizumab-kxwh Subcutaneous and Lotensin HCT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: benazepril / hydrochlorothiazide
Brand name: Lotensin HCT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Loteprednol
- Emicizumab-kxwh Subcutaneous-Loteprednol and Tobramycin
- Emicizumab-kxwh Subcutaneous-Loteprednol and tobramycin ophthalmic
- Emicizumab-kxwh Subcutaneous-Loteprednol Etabonate
- Emicizumab-kxwh Subcutaneous-Loteprednol Eye Drops
- Emicizumab-kxwh Subcutaneous-Loteprednol Eye Drops 0.2%
- Lotensin HCT-Emla
- Lotensin HCT-Emla Topical
- Lotensin HCT-Emo-Cort Scalp Solution Topical application
- Lotensin HCT-Emo-Cort Topical application
- Lotensin HCT-Emoquette
- Lotensin HCT-Empagliflozin